About This Study
The purpose of this study is to see if adding the medicine zolbetuximab to pembrolizumab and chemotherapy is safe and works better for people with certain types of advanced stomach cancer. Researchers will compare this treatment with pembrolizumab and chemotherapy without zolbetuximab. This study is for volunteers diagnosed with gastric or gastroesophageal junction adenocarcinoma that has spread, cannot be removed by surgery, or has grown into nearby areas.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Charlotte, NC
- Greater Winston-Salem, NC